Immune System and Disorders Journal

About The Journal Open Access

Immune System and Disorders Journal

Immune System and Disorder Journal is a Peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contributions towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to maintain quality.

Aims and Scope

Immune System and Disorder Journal that aims to publish the most complete and reliable source of information on discoveries and current developments in the field as original articles, review articles, case reports, short communications and making them available online without any restrictions or subscriptions to the researchers worldwide. The journal is using Editorial Manager System for quality in the review process.

Immune System and Disorder Journal is the unique platform for discussion that covers the topics such as Immunity, Immune System, Immune Disorder, Cell Mediated Immune Disorder, immune system boosters, Tumor Immunology, Immune mechanisms and its evolution, Theoretical approaches of Immune System. Focus of the high impact factor journal is the disease process explanation and organization procedures ensuring in enhanced outcomes for the patient. Patient perspective satisfaction, healthy life, quality treatment, communication and health literacy and their role in developing new health care programs and clinical outcomes are major areas of interest for this journal.

Immune system and Disorder Journal is using Tracking System for easy online tracking and managing of the manuscript processing. Each article undergoes a peer review process under the aegis of an assigned Editor.

You may submit manuscripts online at www.editorialmanager.com/scholarlyjournals/ or you may send the article as an email attachment to [email protected] or [email protected]

Please submit your manuscript to
[email protected]

Just Published Articles

Review Article August 31, 2017

P.1-7

Immune Syst Disord J: 1(2): 1-7

What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

D errico G, Miranda J, Ostios L, Villamayor J

Short Communication August 01, 2017

P.1-5

Immune Syst Disord J: 1(2): 1-5

Human Visceral Leishmaniosis: Epidemiological Analysis of the Brazilian Territory.

Brasileiro MR

Review Article June 14, 2017

P.1-12

Immune Syst Disord J: 1(2): 1-12

Harnessing the Immune Regulatory Balance of Toll-like Receptor 9 Agonists in Cancer Immunotherapy.

Cui J, Bai L, Zhou L, Chen W, Chen J

Review Article June 08, 2017

P.1-4

Immune Syst Disord J: 1(2): 1-4

Esquisse of the Epidemiological Scenario of Chagas Disease in Brazil.

Brasileiro MR